PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 2016Journal of ExtraCorporeal Technology73 citationsOpen Access

Review of Venoarterial Extracorporeal Membrane Oxygenation and Development of Intracardiac Thrombosis in Adult Cardiothoracic Patients

BWBrittney WilliamsWBWendy K. Bernstein

Key Result

In a review of 12 adult cardiothoracic patients who developed intracardiac thrombosis while on venoarterial extracorporeal membrane oxygenation, mortality was high, with only 2 patients surviving.

Structured PICO

What are the clinical characteristics and outcomes of intracardiac thrombosis complicating VA ECMO in adult cardiothoracic patients?

P
Population
12 adult cardiothoracic patients with postcardiotomy cardiogenic shock and heart failure treated with VA ECMO who developed intracardiac thrombosis
I
Intervention
Venoarterial extracorporeal membrane oxygenation (VA ECMO)
O
Outcome
Characteristics, location, and survival outcomes of intracardiac thrombosissafety

Intracardiac thrombosis during VA ECMO is a highly fatal complication that frequently occurs despite perceived adequate systemic anticoagulation, highlighting the need for vigilant monitoring.

Limitations

  • Low incidence of VA ECMO-associated ICT in adult cardiac patients yielding limited clinical information
  • Certain findings were extrapolated from the pediatric to the adult population
  • Pediatric patients were not included in the review despite a larger body of literature

Abstract

Venoarterial extracorporeal membrane oxygenation (VA ECMO) has become an indispensable treatment option for adult cardiothoracic patients experiencing acute refractory cardiogenic shock. VA ECMO is not without inherent complications as in-hospital mortality has ranged from 45% to 65% (1-3). Intracardiac thrombosis (ICT) is a rare but life-threatening complication associated with VA ECMO. VA ECMO cases complicated by ICT were searched for using the MEDLINE (PubMed and OVID), Society of Cardiovascular Anesthesiology Headquarters, and Google Scholar databases. Twelve cases of VA ECMO-associated ICT were discovered for review. Indications for VA ECMO were postcardiotomy cardiogenic shock and heart failure. The primary location of thrombus was the left ventricle and aortic root. Majority of the cases did not report subtherapeutic systemic anticoagulation. Two patients survived after the development of ICT. VA ECMO-associated ICT is a devastating consequence with high mortality. The majority of ICT occurred in cases with perceived adequate anticoagulation, but this may not result in complete suppression of the coagulation response. Continued exposure to procoagulant stimuli and worsening ventricular function and intracardiac stasis can shift the balance toward a hypercoagulable state and development of thrombosis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Williams et al. (2016) conducted a review in Venoarterial extracorporeal membrane oxygenation (VA ECMO)-associated intracardiac thrombosis (n=12). Venoarterial extracorporeal membrane oxygenation (VA ECMO) was evaluated on Survival after development of intracardiac thrombosis. In a review of 12 adult cardiothoracic patients who developed intracardiac thrombosis while on venoarterial extracorporeal membrane oxygenation, mortality was high, with only 2 patients surviving.

synapsesocial.com/papers/6a09480287ad1657d2512331https://doi.org/10.1051/ject/201648162
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The delicate balance between pro-(risk of thrombosis) and anti-(risk of bleeding) coagulation during extracorporeal membrane oxygenation2016 · 19 citations
  2. 2Unfractionated Heparin Activity Measured by Anti-Factor Xa Levels Is Associated With the Need for Extracorporeal Membrane Oxygenation Circuit/Membrane Oxygenator Change2014 · 77 citations
  3. 3Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation*2013 · 139 citations
  4. 4Comparative Performance of Three Anti–Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin2006 · 36 citations
  5. 5Anti-Xa Directed Protocol for Anticoagulation Management in Children Supported With Extracorporeal Membrane Oxygenation2015 · 60 citations